Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
“CGRP-remmers zijn nog geen game-changer”
mrt 2019 | Hoofdpijn